Home OBaris

OBaris

acquired
-
Drug Delivery Technology R&D Developer
Basic
Enterprise Profile

Basic Information

OBaris Develops a Drug Delivery Technology Designed to Replace Painful Injections. The company offers a small, needle-free patch that can be self-applied inside the cheek, allowing patients with chronic conditions to take peptide and protein drugs in a painless and convenient manner.
OBaris AG
Switzerland
less than 15 people
--
info@obaris.ch

Enterprise Profile

Industrial Sector
Medical Device R&D and Design Medical Consumables Manufacturing
Concept
Chronic Disease
Application Scenarios
Medical Device Consumables